Does ALOGLIPTIN\METFORMIN Cause Off label use? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Off label use have been filed in association with ALOGLIPTIN\METFORMIN. This represents 9.4% of all adverse event reports for ALOGLIPTIN\METFORMIN.
35
Reports of Off label use with ALOGLIPTIN\METFORMIN
9.4%
of all ALOGLIPTIN\METFORMIN reports
3
Deaths
21
Hospitalizations
How Dangerous Is Off label use From ALOGLIPTIN\METFORMIN?
Of the 35 reports, 3 (8.6%) resulted in death, 21 (60.0%) required hospitalization, and 1 (2.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALOGLIPTIN\METFORMIN. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does ALOGLIPTIN\METFORMIN Cause?
Diarrhoea (34)
Pneumonia (24)
Pemphigoid (19)
Disease recurrence (18)
Drug ineffective (17)
Hypertension (17)
Lactic acidosis (17)
Tonsil cancer (16)
Blood pressure increased (15)
Appetite disorder (14)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ALOGLIPTIN\METFORMIN Alternatives Have Lower Off label use Risk?
ALOGLIPTIN\METFORMIN vs ALOGLIPTIN\PIOGLITAZONE
ALOGLIPTIN\METFORMIN vs ALOSETRON
ALOGLIPTIN\METFORMIN vs ALPELISIB
ALOGLIPTIN\METFORMIN vs ALPHA.-LIPOIC ACID
ALOGLIPTIN\METFORMIN vs ALPHA.-TOCOPHEROL